In terms of AR specifically in biliary tract cancer, structural variants have been associated with a risk of gallbladder cancer, and AR signaling has been implicated in hepatocellular cancer development although there has not been a direct link with cholangiocarcinoma [46, 47]. The gene discussed is AR; the disease is hepatocellular carcinoma.